Therapeutic development for pancreatic cancer via cancer specific glucose metabolism
Project/Area Number |
16K10604
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Kumamoto University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
澤山 浩 熊本大学, 医学部附属病院, 非常勤診療医師 (40594875)
今井 克憲 熊本大学, 大学院生命科学研究部(医), 助教 (60555746)
東 孝暁 熊本大学, 医学部附属病院, 非常勤診療医師 (70594878)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 膵臓外科学 / 癌糖代謝 / Glut1 |
Outline of Final Research Achievements |
The diagnosis of malignant diseases has been determined using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Glucose transporter type 1 (Glut-1) is a key protein associated with the accumulation of FDG in cancer cells. In this study the expression of Glut-1 and the corrected maximum standardized uptake value (cSUVmax) of FDG-PET were examined in 138 surgically resected pancreatic cancers. Glut-1 was positive in 69 patients. The median relapse-free and overall survival times were significantly shorter in the Glut-1-positive group (11 vs. 22 months, respectively) than in the Glut-1-negative group (23 vs. 42 months, respectively). The cSUVmax was significantly associated with long-term survival. The relapse free and overall survival rates were significantly poorer in the high-cSUVmax group than in the low-cSUVmax group. Glut-1 expression was associated with cSUVmax accumulation. In the multivariate analysis, high cSUVmax was identified as an independent prognostic factor.
|
Academic Significance and Societal Importance of the Research Achievements |
膵癌は多くの症例で発見時既に切除不能である。また切除可能であっても、術後ほとんどの症例で再発をきたす難治性癌である。現在手術や抗がん剤による化学療法が治療の中心であるが、膵癌の更なる予後向上のために新しい治療法の開発は必要不可欠である。 今回我々は癌細胞にグルコースを能動的に取り込むGlucose transporter 1: Glut1がある一定の膵癌患者の癌細胞の表面に多く発現していることを示した。Glut1の発現が多い症例はPET検査におけるFDGの集積も多く、また予後が悪いことが分かった。これは、Glut1をターゲットとした新しい分子標的治療の可能性を示すものである。
|
Report
(4 results)
Research Products
(28 results)
-
[Journal Article] Neuroendocrine Tumor of the Hilar Bile Duct2019
Author(s)
4.Umezaki N, Hashimoto D, Yamashita Y, Nakagawa S, Nakao Y, Itoyama R, Yusa T, Yamao T, Okabe H, Imai K, Hayashi H, Chikamoto A, Baba H.
-
Journal Title
Anticancer Research
Volume: 39
Issue: 2
Pages: 903-907
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Multiple primary cancers in patients with pancreatic cancer.2018
Author(s)
Yamamura K, Hashimoto D, Kitano Y, Kuroda D, Eto T, Arima K, Kaida T, Miyata T, Nakagawa S, Imai K, Yamashita Y, Chikamoto A, Matsumura F, Baba H.
-
Journal Title
Related Report
Peer Reviewed
-
-
-
[Journal Article] Cystic gastric metastasis from pancreatic cancer.2017
Author(s)
Umezaki N, Hashimoto D, Nakagawa S, Yamao T, Tsukamoto M, Kitano Y, Arima K, Yamamura K, Miyata T, Okabe H, Chikamoto A, Matsumura F, Baba H.
-
Journal Title
Surg Case Rep
Volume: in press
Related Report
Peer Reviewed
-
[Journal Article] Preoperative high SUVmax, associated with glucose transporter 1, predicts poor prognosis in pancreatic cancer.2017
Author(s)
Chikamoto A, Inoue R, Komohara Y, Sakamaki K, Hashimoto D, Shiraishi S, Takamori H, Yamashita Y, Yoshida N, Yamanaka T, Yamashita Y, Baba H
-
Journal Title
Ann Surg Oncol
Volume: in press
Issue: 7
Pages: 2040-2046
DOI
Related Report
Peer Reviewed
-
[Journal Article] Efficacy and safety of postoperative anticoagulation prophylaxis with enoxaparin in patients undergoing pancreatic surgery: a prospective trial and literature review.2017
Author(s)
Hashimoto D, Nakagawa S, Umezaki N, Yamao T, MD, Kitano Y, Yamamura K, Kaida T, Arima K, Imai K, Yamashita Y, Chikamoto A, Baba H
-
Journal Title
Pancreatol
Volume: 29
Issue: 3
Pages: 464-470
DOI
Related Report
Peer Reviewed
-
[Journal Article] Shape and enhancement characteristics of pancreatic neuroendocrine tumor on preoperative contrast-enhanced computed tomography may be prognostic indicators.2017
Author(s)
Okabe H, Hashimoto D, Chikamoto A, Morikatsu Y, Taki K, Arima K, Imai K,Tamura Y, Ikeda O, Ishiko T, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Yamashita Y, Yoshizumi T, Beppu T, Yamashita Y, Baba H, Maehara Y.
-
Journal Title
Ann Surg Oncol
Volume: 24(5)
Issue: 5
Pages: 1399-1405
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma2016
Author(s)
Hashimoto D, Arima K, Yokoyama N, Chikamoto A, Taki K, Inoue R, Kaida T, Higashi T, Nitta H, Ohmuraya M, Hirota M, Beppu T, Baba H
-
Journal Title
Pancreas
Volume: 45
Issue: 8
Pages: 1111-1114
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Presentation] Pancreatic cancer arising from the remnant pancreas after pancreatectomy: A multicenter retrospective study2018
Author(s)
Daisuke Hashimoto, Kota Arima, Shigeki Nakagawa, Yuji Negoro, Toshihiko Hirata, Masahiko Hirota, Masafumi Inomata, Kengo Fukuzawa, Takefumi Ohga, Hiroshi Saeki, Eiji Oki, Yo-ichi Yamashita, Akira Chikamoto, Hideo Baba, Yoshihiko Maehara
Organizer
第29回日本消化器癌発生学会総会
Related Report
-
-
[Presentation] Residual total pancreatectomy: technique and outcome.2017
Author(s)
Daisuke Hashimoto, Shigeki Nakagawa, Naoki Umezaki, Yuki Kitano, Kensuke Yamamura, Takayoshi Kaida, Kota Arima, Katsunori Imai, Yo-ichi Yamashita, Akira Chikamoto, Hideo Baba
Organizer
The Joint Congress of the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association & the 29th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Related Report
-
[Presentation] Efficacy and safety of postoperative anticoagulation therapy with enoxaparin in patients undergoing pancreatic surgery: a prospective clinical trial. Poster presentation.2017
Author(s)
Daisuke Hashimoto, Shigeki Nakagawa, Naoki Umesaki, Takanobu Yamao, Yuki Kitano, Kensuke Yamamura, Kota Arima, Takayoshi Kaida, Katsunori Imai, Yo-ichi Yamashita, Akira Chikamoto, Hideo Baba
Organizer
The 49th European Pancreatic Club.
Related Report
-
-
-
-
-
-
-